Recent clinical trial results informing clinical decision making for vedolizumab & anti-IL23 therapy
Dr. Remo Panaccione, an internationally recognized expert in clinical trials discusses the recent data on vedolizumab and anti-IL23 therapies and how those changes impact clinical decision making in IBD
▶︎
Cell-based therapies in IBD incl. hematopoetic stem cell transplantation & CAR T cell therapies
▶︎
Trump Gets Booed and Falls Asleep at NBA Finals, Spreads Deranged CA Election Lies: A Closer Look
▶︎
Understand the hidden biology of longevity
▶︎
How medical guidelines can improve the management of IBD
▶︎
Trump Sells UFC Coins as Iran Strikes & Melania Pushes AI in a Speech Worthy of AI | The Daily Show
▶︎
New Security Strategies & Space Domain Awareness in the Middle East — Panel 6
▶︎
Meet Bruce Sands - breaking the therapeutic ceiling in IBD
▶︎
НАДВИГАЕТСЯ ИНФЛЯЦИОННЫЙ ШТОРМ/ ПРОПАЛА НАБИУЛЛИНА/ ПМЭФ ПОЗОРА/ ИНВЕСТИЦИИ РУХНУЛИ. Милов
▶︎
Emerging and developed market government bonds have "swapped places"
▶︎
Discussion about the role of B cells in health and other autoimmune diseases
▶︎
300,000 years of behaviour
▶︎
Introduction of Florian Rieder as Co-Host of IBD Essentials and Fibrosis in IBD
▶︎
Positive JAZZ - Morning Music To Start The Day
▶︎
Why A Hot Jobs Report Spooked Wall Street
▶︎
Why Leadership Matters More Than Data in Investing with Karim Mawji | The Again...Maybe I Won't
▶︎
Highlights of new treatment options for IBD from recent phase II+III trials, definitions of mild IBD
▶︎
"The ONE FOOD That Can Starve Cancer & Stop Inflammation" - Eat This Every Day | Dr. William Li
▶︎
Introduction of Ailsa Hart as Co-Host of IBD Essentials and Management of Perianal Crohn's disease
▶︎
SpaceX & Open AI Börsengang: Einfluss auf ETFs? Mit Trade Republic teilnehmen?
▶︎